Skip to main content

Table 2 Factors associated with dyslipidaemia from a multiple logistic regression model

From: The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population

Variables

TC ≥ 200 mg/dl

LDL-c ≥ 130 mg/dl

TG ≥ 150 mg/dl

HDL-c < 40 mg/dl

TC/HDL-c ratio ≥5

Adjusted OR (95%CI)

Adjusted OR (95%CI)

Adjusted OR (95%CI)

Adjusted OR (95%CI)

Adjusted OR (95%CI)

Sex

     

Male

1

1

1

1

1

Female

2.11 (0.64-6.95)

0.44 (0.14-1.38)

1.47 (0.53-4.08)

2.55 (0.51-12.64)

3.25 (0.56-18.92)

P-value

0.22

0.16

0.45

0.25

0.19

Age group (years)

     

15 – 24

1

1

1

1

1

25 – 34

0.91 (0.19-4.28)

1.00 (0.03-31.54)

1.20 (0.27-5.30)

1.47 (0.21-10.40)

1.42 (0.19-10.76)

35+

NA

0.28 (0.01-11.70)

NA

NA

NA

P-value

0.56

0.07

0.81

0.70

0.48

CD4 count

     

<350

1

1

1

1

1

350 – 499

1.12 (0.30-4.14)

1.30 (0.38-4.48)

1.23 (0.38-3.89)

1.24 (0.27-5.66)

1.23 (0.33-8.33)

500+

2.45 (0.73-8.26)

0.77 (0.22-2.64)

0.97 (0.33-2.86)

0.57 (0.11-2.76)

1.28 (0.25-6.59)

P-value

0.56

0.07

0.46

0.65

0.48

Time on ART(years)

     

<2

1

1

1

1

1

2 – 4

2.16 (0.64-7.33)

5.22 (1.43-19.06)

0.51 (0.16-1.59)

1.71 (0.34-8.48)

1.65 (0.33-8.33)

5+

1.11 (0.33-3.75)

1.59 (0.45-5.57)

0.66 (0.22-1.91)

2.49 (0.49-12.51)

1.67 (0.30-9.20)

P-value

0.56

0.07

0.46

0.65

0.48

NRTI regimen

     

AZT-based

1

1

1

1

1

D4T-based

2.17 (0.22-21.47)

1.47 (0.08-25.46)

5.29 (0.44-64.26)

5.62 (0.33-95.76)

6.79 (0.40-116.57)

TDF-based

1.89 (0.62-5.80)

1.25 (0.38-4.06)

2.28 (0.79-6.63)

0.74 (0.17-3.26)

1.37 (0.31-6.03)

P-value

0.56

0.07

0.46

0.65

0.48

NNRTI regimen

     

EFV-based

1

1

1

1

1

NVP-based

1.27 (0.42-3.81)

1.20 (0.38-3.76)

0.80 (0.29-2.24)

3.96 (0.85-18.52)

4.09 (0.85-19.73)

P-value

0.67

0.76

0.67

0.08

0.08

Smoking

     

No

1

1

1

NA

NA

Yes

5.84 (0.51-67.18)

15.94 (1.13-225.61)

6.06 (0.44-83.99)

NA

NA

P-value

0.16

0.04

0.18

  

Alcohol intake

     

No

1

1

1

1

1

Yes

0.50 (0.18-1.41)

0.24 (0.07-0.74)

0.99 (0.40-2.47)

0.70 (0.21-2.42)

0.58 (0.15-2.17)

P-value

0.19

0.01

0.99

0.58

0.42

Heart condition

     

No

1

NA

1

NA

NA

Yes

0.47 (0.04-6.15)

NA

0.25 (0.02-3.24)

NA

NA

P-value

0.56

 

0.29

  

Metabolic condition

     

No

1

1

1

1

1

Yes

1.42 (0.21-9.79)

12.54 (1.02-153.86)

2.97 (0.38-22.94)

0.67 (0.06-8.08)

1.02 (0.07-14.69)

P-value

0.72

0.048

0.30

0.75

0.99

Special diet

     

No

1

1

1

1

1

Yes

3.36 (0.56-20.20)

4.19 (0.42-42.07)

1.81 (0.28-11.69)

3.95 (0.45-34.50)

1.06 (0.08-14.17)

P-value

0.19

0.22

0.53

0.22

0.97

ART interruption

     

No

1

1

1

NA

NA

Yes

0.75 (0.05-11.45)

0.89 (0.03-26.83)

7.37 (0.36-149.65)

NA

NA

P-value

0.84

0.95

0.19

  
  1. * ART = antiretroviral therapy, **NRTI = nucleotide reverse transcriptase inhibitors, ***NNRTI = non-nucleotide reverse transcriptase inhibitor, AZT = zidovudine, 3TC = lamivudine, TDF = tenofovir, D4T = stavudine, EFV = efavirenz, NVP = nevirapine, NA = not applicable.